Artist who sued NHS for £3m disability compensation caught dancing
Kae Burnell-Chambers, 44, claimed that delayed diagnosis by NHS doctors had led to nerve damage which left her struggling to walk, get out of a car or even dress herself.
But a video unveiled at the High Court instead showed the artist posing and strutting whilst painted as a fantasy warrior at a festival in 2019.
The video was filmed months before she launched her multimillion pound damages bid over delayed diagnosis of cauda equina syndrome, a condition involving damage to nerves at the end of the spinal cord.
She is now facing a potential jail sentence after Judge Jonathan Glasson KC found her guilty of contempt of court as Ms Burnell-Chambers admitted she had 'misrepresented' her symptoms during the claim.
Sadie Crapper, barrister for Northern Lincolnshire And Goole NHS Foundation Trust, told the court that after NHS doctors missed early signs of the condition in 2016, Ms Burnell-Chambers, from Lincs launched a bid for damages in 2019.
She attended medico-legal appointments complaining of 'a whole array of disabilities,' saying she needed help to dress and to get out of the car - and when she went to see a doctor had 'displayed a laboured gait and used a stick,' the barrister said.
However, she went on to drop her claim in 2022 after social media videos and surveillance footage showed that the picture of her disabilities she had been presenting to support her claim was 'fundamentally dishonest,' said Ms Crapper.
The barrister said Ms Burnell-Chambers said she was 'significantly disabled' by the delayed diagnosis and could walk 'only with a stick' and required aids such as a 'wheelchair, boot hoist and Motability vehicle'.
A core part of the NHS case was based on a series of social media videos that showed her moving 'without any sign of pain'.
One particular video from the Kustom Kulture Blast Off in August 2019 'shows her having her body extensively painted and then parading in a show where she walks freely and dances without need for a walking aid,' the barrister said.
Ms Crapper said that Ms Burnell-Chambers had 'fraudulently exaggerated her symptoms for the purposes of her clinical negligence claim.'
The court heard Ms Burnell-Chambers admitted that her condition varies and her mobility is almost normal on good days, and that she had been exaggerating when she saw the medico legal expert doctor.
'She admitted she had been fundamentally dishonest,' but nevertheless has real 'ongoing disabilities,' her barrister Ben Bradley KC told the court.
The judge, giving his ruling, said she had signed an admission that she had 'deceived' the examining doctors 'and deliberately changed my presentation' and that in doing so had 'deliberately interfered with the administration of justice'.
In her admission statement, she said her mobility is near normal 'on good days,' but 'on bad days' she considers herself to be disabled.
'I know it was wrong to misrepresent my presentation whilst making a civil claim. I accept that I deserve to be punished as a result,' she added.
At the end of a half-day hearing, the judge concluded: 'I find the defendant guilty of contempt of court on the basis of her admissions.'
Ms Burnell-Chambers will now return to court to be sentenced in October. The maximum term for contempt of court is two years' imprisonment.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
BBC News
14 minutes ago
- BBC News
AI app halves wait time for back pain physio in Cambridgeshire
An app that uses artificial intelligence (AI) to provide physiotherapy for people with back pain has cut treatment waiting times by 55%, according to an NHS patients in Cambridgeshire and Peterborough were the first in England to take part in a three-month trial with Cambridgeshire Community Services NHS Trust. The program uses AI to triage, treat and discharge patients and the trust said it allowed about 2,500 hours of clinician time to be diverted to more complex cases, Jayne Davies, the trust's clinical lead for musculoskeletal (MSK) services, said: "A third of our workload is lower back pain and demand outstrips capacity. "If rolled out thoughtfully, this could be a game-changer for patients and the NHS. "Nationally we couldn't train or afford enough staff to meet the rising demand for our services," she added. The app, which was developed by Cambridge-based Flok Health, is the first of its kind to be regulated by the Care Quality Commission. About 80% of adults will experience back pain at some point and MSK disorders were one of the highest causes of work absence and disability in the UK. According to the NHS, waiting times for an appointment with MSK services - which treat muscle, bone and joint problems - is more than 18 weeks. Annys Bossom from Brampton, Cambridgeshire, was among the 2,500 patients who took part in the trial. She has a twisted pelvis, hypermobility and has suffered from back pain for 25 years."At first I was very disappointed to be offered an app but, once I tried it, I really enjoyed it. It was so easy," she said. "I've had lots of treatments in the past, but this offered me exercises I'd never seen before and they've really worked. "Having them demonstrated on the screen was so much more motivating than having them written on a piece of paper - and I could choose when I did them."Sharon McMahon, a primary school teacher from Hardwick, Cambridgeshire, was unable to work for two weeks when she experienced severe back pain. She had been waiting for 17 weeks for treatment when the app became available."I started my treatment the same day, and was able to get appointments and complete exercises whenever I liked. I was back to normal after a couple of weeks." The app assesses a patient's MSK pain through a series of questions before recommending a plan of recorded exercises , which are demonstrated on the screen by Kirsty Henderson, a physiotherapist who has worked for 15 years in the NHS and private sector. MSK patients can refer themselves or be referred by a doctor to Flok's clinic. Data from the trial in Cambridgeshire and Peterborough showed: 80% of patients reported the app to be "equivalent or 'better" than face-to-face care98% of patients were assessed, treated and discharged through the digital clinic and 2% requested or needed a face-to-face referralEach month 856 hours of clinician time were savedOverall waiting times for MSK services fell from 18 weeks to less than 10 weeksWaiting times for back pain treatment fell by 55% As the use of AI in UK healthcare increases, general concerns remain about the protection and quality of the data used to train the models and the need for greater regulation. The Health Foundation charity found in 2024 that one in six people in the UK still feel that AI will make healthcare worse. The charity added that if the government wanted to generally pursue technology as a way to transform the health service, more public engagement was needed. Ms Henderson said she did not think the technology would put physiotherapists out of work."There will always be people who need face-to-face care, and I believe this app will give physios the time they need to treat those more complex cases. "The workload in the NHS was enormous," she said. Finn Stevenson, the app's co-founder, said he was inspired to create the platform after experiencing MSK treatment delays after he retired from rowing professionally."There just aren't enough clinicians to meet demand in a traditional setting. [The app] is like having a video call with one," he said. The Chartered Society of Physiotherapy accepted that long waiting lists for MSK treatment were a problem. Ash James, the society's director of practice and development, said: "There's a crisis in physiotherapy. The demand is high but the NHS in many areas has frozen recruitment. "Back pain is something that, with some support, most people can manage by themselves; so technology like this can really help them get the treatment they need quickly. "AI can help in lots of ways but the technology must be developed alongside physiotherapists, it must be safe and there must be human oversight."Flok Health said that if a patient gives answers that were confusing or alarming, a physiotherapist will be alerted and call the patient and physios and patients can message each other. "At the beginning, I wasn't sure a programme could understand the nuances in the way people describe things - but it does," said Ms added: "It's still really important that we're there to step in where we suspect more urgent or serious problems." Follow Cambridgeshire news on BBC Sounds, Facebook, Instagram and X.
Telegraph
17 minutes ago
- Telegraph
World's biggest study of trans children to include toddlers treated by NHS
The world's biggest study of trans children will include toddlers treated by the NHS. Children who are under 18 and already being treated by an NHS gender clinic for 'gender incongruence' are to be eligible for a new research project which is being launched today by King's College London. The 2024 Cass review found that the youngest child referred to a gender identity service (GIDS) run by the NHS was three years old. All NHS patients under 18 at gender clinics will be eligible for enrolment in the new study. Around 3,000 children and young people are expected to take part with the first participants to be on board by early autumn. The Cass review found that referrals to gender clinics had grown exponentially in the last decade with three-quarters of patients born female, it also found many patients have mental health conditions and autism. The researchers running the Pathways Horizon project expect the findings to shed light on the links between these trends and help unpick any potential mechanism as well as improving treatments. The study will contain ten times as many children as the largest previous studies and the investigators hope the data will provide better information to support trans children, their families and clinicians. Participants will be recruited over 3.5 years and the programme is one of a suite of five projects that received £10.7million in total funding and will run until 2031. One of the sister research projects, Pathways Trial, is planning to look into the role of puberty suppressants on children with gender incongruence and the data will crossover with the Horizon project. This project has not yet been approved by ethics boards or regulators and is not yet underway. The Horizon study launching today is observational and will only follow trans children throughout their normal NHS care and will involve annual questionnaires on wellbeing, mental and physical health, relationships and gender identity. Some of the main goals of the work are to understand how prevalence of gender incongruence — defined as a marked and persistent split between an individual's experienced gender and assigned sex — changes depending on sex, neurodivergence, autism, ADHD and other conditions. Dr Michael Absoud, a consultant in Paediatric Neurodisability at King's College London and Deputy Chief Investigator of Horizons said doctors 'know too little' about how different treatments work for their patients. 'This is why we're launching the Pathways Horizons today — to help fill the evidence gap,' he said. 'We know that a significant number of young people referred to the gender services are also neurodivergent, particularly those with autism, ADHD, or other cognitive differences and this study will help, in the future, to understand how neurodivergence intersects and overlaps with gender-related distress, and whether different types of support are needed to meet the unique needs of these young people presenting to our services. 'Ultimately, our goal is to help and shape the future services to help children, improve child health, support families, and also clinicians.' Little reliable data There is relatively little reliable data from large studies that follow participants for several years specifically on trans children and this study is designed to fill this void. Professor Emily Simonoff, Professor of Child and Adolescent Psychiatry at King's College London and Chief Investigator of the study, said NHS England decided a study was needed to improve knowledge following the Cass review. 'We were tasked as a group to develop a robust program of research that would address questions raised in the Cass report,' she said. 'We were not told what to do. This is a study that we designed as a group of investigators.' The scientists are hoping the work will improve knowledge on the characteristics of people using youth gender services and also will compare the results of different treatment approaches while following the children in greater detail than ever before. 'More comprehensive' analysis Professor Richard Emsley, the study's statistician at King's College London, said the analysis will be more comprehensive than previous work. 'This will include first childhood experiences, social transitioning, neurodiversity such as autism and ADHD, and mental health symptoms including anxiety, depression, eating problems, and difficulty managing emotions,' he said. He added that the first papers from the trial will be published in a couple of years and will likely shed light on who is most likely to be using the NHS gender clinics as children. 'This includes their demographic characteristics, the prevalence of birth registered sex, and co-occurring conditions such as autism and ADHD.' He added: 'We won't be directly comparing different interventions. The best way to compare different interventions is in randomised control trials, but it will help us understand, for example, which groups of children and young people need more intensive input, which ones need less intensive input. 'It will help us to identify whether certain kinds of treatment packages seem to be more linked with good outcomes than others. 'That will allow us to develop further research in the future to pit interventions against each other or develop them in more detail.'
Daily Record
an hour ago
- Daily Record
Scots mum issues dry nappy warning after toddler diagnosed with stage four cancer
Little Tommy Quinn, three, was diagnosed with high risk neuroblastoma after his mum Nicole became concerned about his dry nappy. A mum has issued a dry nappy warning to parents after her two-year-old son was diagnosed with stage four cancer. Little Tommy Quinn, now three, was diagnosed with high risk neuroblastoma - an aggressive form of a childhood cancer that originates in immature nerve cells - in April last year. The tot was rushed to A&E by mum Nicole and dad David after he failed to soil his nappy for more than a day. He was also struggling to sleep, lost his appetite and had a sudden bout of sickness. Recalling her son's devastating diagnosis, Nicole, 38, from Bishopbriggs, told the Record: "It was terrifying and all happened so quickly. He went off his food, was struggling to sleep through the night and had a bit of sickness. "But when he didn't wet his nappy for a whole day, we took him to A&E. We were sent home on suspicion that it could have been a viral infection but he was sick again so we took him back - at that point, he still wasn't giving us any wet nappies. "They couldn't find anything wrong until somebody felt his tummy and found a mass. I thought he had constipation and that his bowel was pressing against his bladder. "Just days later, we discovered he had cancer. Everything just spiralled from there. "The whole month before his diagnosis, his sleeping and eating were terrible but I just put it down to development. The thought of cancer never even crossed my mind because he was a happy, lively and energetic toddler. "It shows you the importance of checking things like prolonged periods of dry nappies. It can be a sign of dehydration but it must be taken seriously." Brave Tommy underwent eight gruelling rounds of chemotherapy and radiotherapy before undergoing numerous bone marrow procedures, blood transfusions, a stem cell harvest, a tumour re-section and a stem cell transplant. Nicole said: "He's amazed us all with his resilience and strength. "Despite everything he's been through, he keeps his cheeky smile and mischievous nature. "It has been a terrifying journey so far but we're so proud of how he is coping daily, he takes it all in his stride." The little warrior is currently receiving immunotherapy, which is due to conclude in the coming weeks. His family will find out in September if his cancer is in remission. While there's currently no signs that the disease is spreading, Tommy's family and friends are fundraising for therapy not available on the NHS as he will remain at high risk of relapse. The treatment, called DFMO - a drug that has shown promise as a treatment option for high-risk neuroblastoma - will keep the cancer at bay and give him the best chance at life. It will cost around £250,000 and will require the family to travel to the US. Nicole said: "Even after completing this intensive course of treatment, there is still a very high risk that Tommy could relapse and his cancer could come back, which is frighteningly common with high risk neuroblastoma. "If this happens, Tommy's chances of survival would drop drastically to between five and 10 per cent. "The treatment will give us a higher chance of keeping him in remission, we want to give him the best chance at beating this awful disease."
